Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Randomized, Placebo-controlled, Feasibility Study to Evaluate Efficacy of Dietary Ingredient in Vitality & Metabolic Factors in Healthy Individuals
Authors not listed
Vedic Lifesciences Pvt. Ltd. · 2024
Abstract
The present study is a randomized, placebo-controlled, feasibility study to evaluate efficacy of dietary ingredients in vitality \& metabolic factors in healthy individuals. Approximately 54 subjects aged between ≥ 40 and ≤ 60 years will be screened and 36 participants (12 in each arm) are to be randomized. Both the IP and placebo study arms will have 10 completed subjects in each arm after accounting for the screening failure and dropout/withdrawal rate of 30% and 17% respectively (Total 30 completers). The treatment duration for all the study subjects will be 90 days.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Anonymous. (2024). A Randomized, Placebo-controlled, Feasibility Study to Evaluate Efficacy of Dietary Ingredient in Vitality & Metabolic Factors in Healthy Individuals. <em>Vedic Lifesciences Pvt. Ltd.</em>. https://clinicaltrials.gov/study/NCT06188949
Vancouver
Anonymous. A Randomized, Placebo-controlled, Feasibility Study to Evaluate Efficacy of Dietary Ingredient in Vitality & Metabolic Factors in Healthy Individuals. Vedic Lifesciences Pvt. Ltd.. 2024.
BibTeX
@misc{anon2024ARando,
title = {A Randomized, Placebo-controlled, Feasibility Study to Evaluate Efficacy of Dietary Ingredient in Vitality & Metabolic Factors in Healthy Individuals},
author = {Anonymous},
journal = {Vedic Lifesciences Pvt. Ltd.},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Abinopharm, Inc 2021
Open access · US-GOV
A Multi Center Two Part Study to Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults
Yonsei University 2026
Open access · US-GOV
Efficacy of Lecanemab in Patients With Parkinson's Disease With Coexistent Alzheimer's Disease
University of California, Irvine 2022
Open access · US-GOV
Using Nicotine to Reverse Age-related Auditory Processing Deficits: Human Psychophysics and Electrophysiology
Kocaeli City Hospital 2026
Open access · US-GOV
The Effects of Multidimensional Frailty Phenotypes, Immunonutritional Status, and Surgical Approach on Biological Recovery in Elderly Patients Undergoing Gastric Cancer Surgery: A Prospective Observational Study
JHSPH Center for Clinical Trials 2009
Open access · US-GOV
A Multi-Center Randomized Placebo-Controlled Clinical Trial Study of Citalopram for the Treatment of Agitation in Alzheimer's Disease
VA Boston Healthcare System 2018
Open access · US-GOV